AI Terminal
Muenchener Rueckversicherungs-Gesellschaft AG
Interim / Quarterly Report • Nov 11, 2025
6208_rns_2025-11-11_07cd75e1-3d0b-45eb-8170-5ca4eeff6959.pdf
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
{0}------------------------------------------------
Quarterly statement: Munich Re generates net result of €2bn in Q3 and confirms annual guidance of €6bn
- − Net result rises to €5.2bn for Q1–3
- − Property-casualty reinsurance & Global Specialty Insurance: Belowaverage major-loss expenditure ensures low combined ratios in Q3: 62.7% & 82.8%
- − Life and health reinsurance: Unfavourable claims experience in Q3 dampens total technical result (€314m); strong new business particularly in the US and UK
- − ERGO: High contribution of €304m to net result
- − Outlook confirmed: Munich Re expects net result of €6.0bn in 2025
"Munich Re generated a high net result of just under €2bn in the third quarter. We are therefore fully on track to achieve our target of €6bn for the full year. The main reasons for the outstanding quarterly result were the excellent combined ratios in property-casualty reinsurance and Global Specialty Insurance, in addition to good operating performance overall. These ratios reflect a below-average major-loss expenditure. Together with the excellent performance at ERGO and a high investment result, we were thus able to more than compensate for a somewhat weaker quarter in life reinsurance, and for currency losses. Our diversification strategy is working."
Christoph Jurecka, Chief Financial Officer
{1}------------------------------------------------
Summary of Q3 figures1,2
In Q3 2025, Munich Re generated a net result of €1,997m (907m), and €5,176m (4,623m) in Q1–3. Insurance revenue from insurance contracts issued fell to €14,575m (15,496m) and to €45,162m (45,510m) in Q1–3, due primarily to negative currency translation effects. In Q3, the total technical result increased to €2,822m (1,696m). Owing mainly to foreign exchange losses against the US dollar, the currency result amounted to –€189m (–462m). The operating result rose significantly to €3,036m (1,161m), while the effective tax rate was 32.9% (17.8%).
Equity was slightly lower at the reporting date (€32,414m) than at the start of the year (€32,901m). This was due primarily to dividends and share buy-backs as well as currency translation effects. Munich Re's solvency ratio3 increased slightly to 293% (31 December 2024: 287%), thus remaining above the target corridor of 175–220%.
In Q3 2025, the annualised return on equity (RoE) amounted to 24.2% (11.5%), and to 20.8% (19.9%) in Q1–3.
Reinsurance: Result of €1,693m1
Munich Re has reported Global Specialty Insurance (GSI) as a separate segment within the reinsurance field of business since the first quarter of 2025. GSI bundles the global specialty primary insurance activities insofar as they are managed by the reinsurance organisation. They were previously part of the property-casualty reinsurance segment. The comparative figures have been adapted accordingly.
The reinsurance field of business contributed €1,693m (766m) to the net result in Q3 and €4,380m (3,993m) in Q1–3. Insurance revenue from insurance contracts issued declined to €9,262m (10,224m) in Q3. The total technical result increased to €2,190m (1,198m) and the operating result climbed to €2,477m (956m).
The total technical result in the life and health reinsurance segment decreased to €314m (507m) in Q3, due primarily to unfavourable claims experience which, however, remained within the scope of normal fluctuations. The segment result declined to
1 Prior-year figures adjusted due to a reclassification of currency translation differences on insurance-related financial instruments to the currency result.
2 Previous year's figures adjusted due to a change in the accounting policy for recognising acquisition costs in the ERGO Germany segment.
3 Does not include transitional measures or, as at 30 September 2025, any deduction for dividends for the financial year 2025 to be paid in 2026.
{2}------------------------------------------------
€286m (481m). Insurance revenue from insurance contracts issued amounted to €2,868m (2,936m).
The net result in the property-casualty reinsurance segment rose significantly to €1,187m (263m) in Q3, due primarily to a very low major-loss expenditure. Insurance revenue from insurance contracts issued decreased to €4,241m (5,055m), due mainly to the low US dollar exchange rate and the deliberate discontinuation of business that no longer met our return requirements. The combined ratio improved to 62.7% (89.5%) of net insurance revenue; the normalised combined ratio was 78.7%.
The major-loss expenditure in the property-casualty reinsurance segment fell significantly to €118m (1,336m) after retrocessions and before taxes. This amount includes run-off profits and losses for major claims from previous years, and is equivalent to 2.9% (27.8%) of net insurance revenue, significantly below the expected figure of 17%. A release of €47m was recorded for major losses from natural catastrophes in Q3, after an expenditure of €1,137m had been recognised in the prioryear quarter due to several major loss events in the US, Canada, and Central and Eastern Europe. Man-made major losses amounted to €165m (199m). The major-loss figures provided above take account of the effects from discounting and risk adjustment.
The GSI segment generated a net result of €221m (22m) in Q3; insurance revenue from insurance contracts issued amounted to €2,153m (2,233m). The combined ratio improved to 82.8% (92.6%) of net insurance revenue, in particular due to the decrease in major-loss expenditures to €59m (273m) (after retrocessions and before taxes), which corresponds to 2.9% (12.6%) of net insurance revenue.
ERGO: Result of €304m2
Munich Re generated an extraordinarily good result of €304m (141m) in its ERGO field of business in Q3 and €796m (629m) in Q1–3. This development was supported by a number of one-off effects, which had a cumulative positive impact on the net result of ca. €50m. Insurance revenue from insurance contracts issued rose to €5,313m (5,271m) in Q3 and to €16,019m (15,553m) in Q1–3.
The ERGO International segment's net result increased to €324m (23m). The total technical result increased significantly compared to the prior-year quarter, due primarily to very good operating performance in the major international property-casualty markets and a higher release of the contractual service margin in life and health. The segment's investment result benefited from a one-off effect in connection with the complete takeover of the US insurer NEXT Insurance. On 1 July 2025, Munich Re
{3}------------------------------------------------
acquired the remaining approx. 71% of the voting shares in NEXT Insurance. As a result, Munich Re increased its stake to 100%.
ERGO Germany generated a net result of –€21m (118m), burdened by a negative oneoff effect in connection with the reduction in corporation tax from 2028. The segment's technical result improved compared to the prior-year quarter, driven in particular by the health and travel business. The short-term health and travel business recorded an increase in the technical result due to lower claims and seasonal effects. The release of the contractual service margin in life and health was slightly higher than in the prioryear quarter. In the German property-casualty business, the technical result was on par with the prior-year quarter.
The total technical result for the ERGO field of business in Q3 increased to €632m (498m), while the operating result rose to €560m (205m). The combined ratio in the ERGO Germany segment was 88.7% (88.8%) in Q3 and 88.8% (89.2%) in Q1–3. This corresponds to the target figure for the year as a whole. In the ERGO International segment, the ratio improved significantly to 88.7% (96.1%) in Q3 and to 89.1% (92.4%) in Q1–3; it was therefore below the target value for the year as a whole. The ratio in Q3 2024 was negatively impacted by the catastrophic flooding in Central and Eastern Europe.
Investments: Investment result of €2,385m
Munich Re's investment result increased to €2,385m (2,091m) in Q3; regular income from investments amounted to €2,092m (2,026m). The balance from write-ups and write-downs was –€51m (–138m); the balance from gains and losses on the disposal of investments rose to €337m (–115m). The change in fair value amounted to €215m (467m).
The higher investment result compared to the prior-year quarter was due primarily to the increased regular income and the higher result from the disposal of investments. This was realised primarily through the complete takeover of NEXT Insurance and the resulting effect on profits in Q3. In addition, the fair values of equities contributed to the positive net result due to stronger equity markets.
Overall, the Q3 investment result represents a return of 4.1% on the average market value of the portfolio. The running yield was 3.6% and the yield on reinvestment was 4.0%. As at 30 September 2025, the equity-backing ratio including equity-linked derivatives amounted to 2.9% (31 December 2024: 2.9%). The carrying amount of the investment portfolio as at 30 September 2025 was €225,575m (230,716m).
{4}------------------------------------------------
Outlook for 2025: Annual guidance unchanged at €6bn
Munich Re is well positioned to achieve its guidance of €6bn for the year. In reinsurance, insurance revenue of €39bn (previously €40bn) is now expected due to premium adjustments, the effects of renewals, and exchange rate developments. The insurance revenue forecast for the Group is therefore €61bn (previously €62bn). Mainly due to low major-loss expenditures, a combined ratio of around 74% (previously around 79%) is now expected in the property-casualty reinsurance segment, while a combined ratio of about 87% (previously approximately 90%) is now forecast for the GSI segment. All other expectations for 2025 remain unchanged compared to the information in the 2025 half-year financial report published in August.
Please note that all figures are rounded values. As usual, all forecasts and targets are subject to increased uncertainties stemming from geopolitical and macroeconomic developments, to major losses remaining within normal bounds, and to the income statement not being impacted by severe fluctuations in the currency or capital markets, significant changes in the tax environment, or other one-off effects.
Munich Reinsurance Company Aktiengesellschaft in München Group Media Relations Königinstraße 107, 80802 München
LinkedIn: https://www.linkedin.com/company/munich-re
For media inquiries, please contact
Group Media Relations Stefan Straub Tel.: +49 89 3891 9896 Mobile: +49 151 64 93 30 48
Faith Thoms Tel.: +65 63180762 Mobile: +65 83390125 [email protected]
Media Relations Asia-Pacific
Financial Communications Axel Rakette Tel.: +49 89 3891 3141 Mobile: +49 151 20 46 21 32 [email protected]
Media Relations North America Ashleigh Lockhart Tel.: +1 609 275-2110 Mobile: +1 980 395 2979 [email protected]
Group Media Relations Irmgard Joas Tel.: +49 89 3891 6188 Mobile: +49 151 52 81 70 24 [email protected]
Media Relations London Market Lillian Ng Tel.: +44 207 8863952 Mobile: +44 7809 495299 [email protected]
Munich Re
Munich Re is one of the world's leading providers of reinsurance, primary insurance and insurance-related risk solutions. The Group consists of the reinsurance and ERGO business segments, as well as the asset manager MEAG. Munich Re is globally active and operates in all lines of the insurance business. Since it was founded in 1880, Munich Re has been known
{5}------------------------------------------------
for its unrivalled risk-related expertise and its sound financial position. Munich Re leverages its strengths to promote its clients' business interests and technological progress. Moreover, Munich Re develops covers for new risks such as rocket launches, renewable energies, cyber risks and artificial intelligence. In the 2024 financial year, Munich Re generated insurance revenue of €60.8bn and a net result of €5.7bn. The Munich Re Group employed about 44,000 people worldwide as at 31 December 2024.
Disclaimer
This media information contains forward-looking statements that are based on current assumptions and forecasts of the management of Munich Re. Known and unknown risks, uncertainties and other factors could lead to material differences between the forward-looking statements given here and the actual development of our Company, in particular the results, financial situation and performance. Munich Re assumes no liability to update these forward-looking statements or to conform them to future events or developments.
{6}------------------------------------------------
Key figures
Munich Re at a glance1
| Q1–3 2025 Q1–3 2024 Change | Q3 2025 | Q3 2024 Change | ||||
|---|---|---|---|---|---|---|
| % | % | |||||
| Net result €m |
5,176 | 4,623 | 12.0 | 1,997 | 907 | 120.1 |
| Thereof attributable to non-controlling interests €m |
2 -1 |
– | -6 | 0 | – | |
| Earnings per share | € 39.73 |
34.67 | 14.6 | 15.48 | 6.85 | 126.0 |
| Return on equity (RoE) % |
20.8 | 19.9 | 24.2 | 11.5 | ||
| Return on investment (Rol) % |
3.4 | 3.4 | 4.1 | 3.6 |
| 30.9.2025 31.12.2024 | Change | |||
|---|---|---|---|---|
| % | ||||
| Share price | € | 543.40 | 487.10 | 11.6 |
| Munich Reinsurance Company's market capitalisation | €bn | 71.0 | 65.2 | 9.0 |
| Carrying amount per share | € | 250.02 | 249.58 | 0.2 |
| Investments | €m | 225,575 | 230,716 | -2.2 |
| Investments for unit-linked life insurance | €m | 9,684 | 9,186 | 5.4 |
| Equity | €m | 32,414 | 32,901 | -1.5 |
| Insurance contracts issued and reinsurance contracts held (net) | €m | 205,874 | 211,461 | -2.6 |
| Balance sheet total | €m | 279,128 | 286,442 | -2.6 |
| Number of staff | 44,043 | 43,584 | 1.1 |
Reinsurance2,3
| Q1–3 2025 Q1–3 2024 Change | % | Q3 2025 | Q3 2024 Change | % | |||
|---|---|---|---|---|---|---|---|
| Insurance revenue from insurance contracts issued | €m | 29,143 | 29,957 | -2.7 | 9,262 | 10,224 | -9.4 |
| Total technical result Life and health | €m | 1,226 | 1,559 | -21.3 | 314 | 507 | -38.1 |
| Combined ratio – Property-casualty | % | 69.8 | 77.9 | 62.7 | 89.5 | ||
| Combined ratio – Global Specialty Insurance | % | 85.8 | 91.3 | 82.8 | 92.6 | ||
| Investment result | €m | 3,115 | 2,617 | 19.0 | 1,128 | 804 | 40.4 |
| Net result | €m | 4,380 | 3,993 | 9.7 | 1,693 | 766 | 121.0 |
| Thereof: Reinsurance – Life and health | €m | 1,131 | 1,481 | -23.6 | 286 | 481 | -40.5 |
| Thereof: Reinsurance – Property-casualty | €m | 2,724 | 2,273 | 19.8 | 1,187 | 263 | 351.0 |
| Thereof: Global Specialty Insurance | €m | 525 | 239 | 119.5 | 221 | 22 | 889.1 |
| Return on equity (RoE) | % | 21.5 | 20.4 | 25.0 | 11.4 |
ERGO1,3
| Q1–3 2025 Q1–3 2024 Change | Q3 2025 | Q3 2024 Change | |||||
|---|---|---|---|---|---|---|---|
| % | % | ||||||
| Insurance revenue from insurance contracts issued | €m | 16,019 | 15,553 | 3.0 | 5,313 | 5,271 | 0.8 |
| Combined ratio – Property-casualty Germany | % | 88.8 | 89.2 | 88.7 | 88.8 | ||
| Combined ratio – International | % | 89.1 | 92.4 | 88.7 | 96.1 | ||
| Investment result | €m | 2,780 | 3,107 | -10.5 | 1,256 | 1,287 | -2.4 |
| Net result | €m | 796 | 629 | 26.5 | 304 | 141 | 115.4 |
| Thereof: ERGO Germany | €m | 275 | 395 | -30.4 | -21 | 118 | – |
| Thereof: ERGO International | €m | 521 | 234 | 122.3 | 324 | 23 >1.000,0 | |
| Return on equity (RoE) | % | 17.6 | 17.2 | 20.5 | 11.9 |
Previous year´s figures adjusted due to an accounting policy change for recognition of acquisition costs in the segment ERGO Germany.
Previous year's figures adjusted due to a reclassification of currency translation differences on insurance-related financial instruments to the currency result.
Previous year's figures adjusted due to change in segment reporting.
{7}------------------------------------------------
Outlook Munich Re (Group) 2025
| As at | As at | ||
|---|---|---|---|
| 30.09.2025 | 30.06.2025 | ||
| Insurance revenue from insurance contracts issued | €bn | 61 | 62 |
| Total technical result – Life and health reinsurance | €bn | 1.7 | 1.7 |
| Combined ratio – Property-casualty reinsurance | % | 74 | 79 |
| Combined ratio – Global Specialty Insurance | % | 87 | 90 |
| Combined ratio – ERGO Property-casualty Germany | % | 89 | 89 |
| Combined ratio – ERGO International | % | 90 | 90 |
| Return on investment | % | over 3.0 | over 3.0 |
| Net result | €bn | 6.0 | 6.0 |
| Economic Earnings | €bn | over 6.0 | over 6.0 |
{8}------------------------------------------------
Investment result
| Q1–3 2025 | RoI1 | Q1–3 2024 | RoI1 | Q3 2025 | Q3 2024 | |
|---|---|---|---|---|---|---|
| €m | % | €m | % | €m | €m | |
| Regular income | 6,403 | 3.7 | 6,114 | 3.6 | 2,092 | 2,026 |
| Write-ups/write-downs | -118 | -0.1 | -248 | -0.1 | -51 | -138 |
| Change in expected credit losses | 2 | 0.0 | 10 | 0.0 | -9 | 32 |
| Gains/losses on disposal | 374 | 0.2 | -316 | -0.2 | 337 | -115 |
| Fair value changes | -229 | -0.1 | 660 | 0.4 | 215 | 467 |
| Other income/expenses | -537 | -0.3 | -496 | -0.3 | -200 | -182 |
| Total | 5,894 | 3.4 | 5,724 | 3.4 | 2,385 | 2,091 |
Annualised return in % p.a. on the average fair value of the investment portfolio at the quarterly reporting dates.
{9}------------------------------------------------
Consolidated balance sheet1
Assets
| Assets | ||||||
|---|---|---|---|---|---|---|
| 30.9.2025 | 31.12.2024 | Change | ||||
| €m | €m | €m | €m | €m | % | |
| A. Intangible assets | ||||||
| I. Goodwill | 4,705 | 3,443 | 1,262 | 36.6 | ||
| II. Other intangible assets | 1,134 | 819 | 315 | 38.4 | ||
| 5,838 | 4,262 | 1,576 | 37.0 | |||
| B. Reinsurance contracts held that are assets | 3,672 | 4,123 | -451 | -10.9 | ||
| C. Insurance contracts issued that are assets | 6,854 | 7,208 | -354 | -4.9 | ||
| D. Investments | ||||||
| I. Non-financial investments | ||||||
| 1. Investment property |
9,782 | 10,189 | -408 | -4.0 | ||
| 2. Property, plant and equipment |
860 | 405 | 455 | 112.3 | ||
| 3. Intangible assets |
73 | 74 | 0 | 0.0 | ||
| 4. Biological assets |
1,163 | 1,202 | -39 | -3.2 | ||
| 5. Inventories |
9 | 12 | -3 | -21.5 | ||
| 6. Investments in affiliated companies, associates and joint ventures |
||||||
| 4,881 | 5,266 | -385 | -7.3 | |||
| Thereof: Associates and joint ventures accounted for using the equity | ||||||
| method | 4,415 | 4,701 | -286 | -6.1 | ||
| 16,768 | 17,147 | -379 | -2.2 | |||
| II. Financial investments | 208,807 | 213,569 | -4,762 | -2.2 | ||
| 225,575 | 230,716 | -5,141 | -2.2 | |||
| E. Investments for unit-linked life insurance | 9,684 | 9,186 | 498 | 5.4 | ||
| F. Insurance-related financial instruments | 8,684 | 9,563 | -879 | -9.2 | ||
| G. Receivables | ||||||
| I. Current tax receivables | 715 | 690 | 25 | 3.6 | ||
| II. Financial receivables | 3,811 | 4,204 | -393 | -9.3 | ||
| III.Other receivables | 1,818 | 1,703 | 115 | 6.8 | ||
| 6,344 | 6,597 | -253 | -3.8 | |||
| H. Cash and cash equivalents | 5,429 | 6,116 | -688 | -11.2 | ||
| I. Deferred tax assets |
1,810 | 2,591 | -781 | -30.1 | ||
| -15.2 | ||||||
| K. Non-current assets held for sale | 739 | 774 | -35 | -4.5 | ||
| Total assets | 279,128 | 286,442 | -7,314 | -2.6 | ||
| J. Other assets | 4,497 | 5,304 | -807 | |||
| Equity and liabilities | ||||||
| 30.9.2025 | 31.12.2024 | Change | ||||
| A. Equity | €m | €m | €m | €m | €m | % |
| I. Issued capital and capital reserve | 7,425 | 7,422 | 3 | 0.0 | ||
| II. Retained earnings | 21,014 | 19,274 | 1,740 | 9.0 | ||
| III.Other reserves | -1,371 | 397 | -1,768 | – |
| 30.9.2025 | 31.12.2024 | Change | ||||
|---|---|---|---|---|---|---|
| €m | €m | €m | €m | €m | % | |
| A. Equity | ||||||
| I. Issued capital and capital reserve | 7,425 | 7,422 | 3 | 0.0 | ||
| II. Retained earnings | 21,014 | 19,274 | 1,740 | 9.0 | ||
| III.Other reserves | -1,371 | 397 | -1,768 | – | ||
| IV.Net result attributable to Munich Reinsurance Company equity holders | 5,173 | 5,704 | -531 | -9.3 | ||
| V. Non-controlling interests | 173 | 104 | 68 | 65.4 | ||
| 32,414 | 32,901 | -487 | -1.5 | |||
| B. Subordinated liabilities | 7,404 | 6,321 | 1,083 | 17.1 | ||
| C. Reinsurance contracts held that are liabilities | 287 | 523 | -236 | -45.1 | ||
| D. Insurance contracts issued that are liabilities | ||||||
| I. Liability for remaining coverage | 134,202 | 132,560 | 1,642 | 1.2 | ||
| II. Liability for incurred claims | 81,911 | 89,702 | -7,792 | -8.7 | ||
| III.Other technical liabilities | 0 | 7 | -7 | -100.0 | ||
| 216,113 | 222,269 | -6,157 | -2.8 | |||
| E. Other provisions | 2,833 | 2,760 | 72 | 2.6 | ||
| F. Liabilities | ||||||
| I. Derivatives | 704 | 1,274 | -570 | -44.7 | ||
| II. Non derivative financial liabilities | 4,734 | 4,099 | 635 | 15.5 | ||
| III.Current tax liabilities | 2,783 | 2,179 | 604 | 27.7 | ||
| IV.Other liabilities | 10,498 | 12,120 | -1,622 | -13.4 | ||
| 18,719 | 19,671 | -952 | -4.8 | |||
| G. Deferred tax liabilities | 1,305 | 1,973 | -668 | -33.9 | ||
| H. Liabilities related to non-current assets held for sale | 54 | 23 | 31 | 132.8 | ||
| Total equity and liabilities | 279,128 | 286,442 | -7,314 | -2.6 |
Previous year´s figures adjusted due to an accounting policy change for recognition of acquisition costs in the segment ERGO Germany.
{10}------------------------------------------------
Consolidated income statement1,2
| Q1–3 2025 | Q1–3 2024 | Change | |||
|---|---|---|---|---|---|
| €m | €m | €m | % | ||
| 1. | Insurance revenue from insurance contracts issued | 45,162 | 45,510 | -348 | -0.8 |
| 2. | Insurance service expenses from insurance contracts issued | -36,833 | -38,337 | 1,504 | 3.9 |
| Claims expenses | -30,624 | -32,139 | 1,515 | 4.7 | |
| Changes from underlying items | 598 | 400 | 198 | 49.5 | |
| Administration and acquisition costs | -6,806 | -6,598 | -208 | -3.1 | |
| Other insurance service expenses | -1 | 0 | -1 | – | |
| 3. | Insurance service result from insurance contracts issued (1+2) | 8,329 | 7,172 | 1,156 | 16.1 |
| 4. | Insurance revenue ceded from reinsurance contracts held | -1,171 | -1,355 | 184 | 13.6 |
| 5. | Income from reinsurance contracts held | 388 | 552 | -164 | -29.7 |
| 6. | Insurance service result from reinsurance contracts held (4+5) | -783 | -803 | 21 | 2.6 |
| 7. | Insurance service result (3+6) | 7,546 | 6,369 | 1,177 | 18.5 |
| 8. | Result from insurance-related financial instruments | 364 | 413 | -49 | -11.8 |
| 9. | Total technical result (7+8) | 7,910 | 6,782 | 1,128 | 16.6 |
| 10. | Investment result | 5,894 | 5,724 | 170 | 3.0 |
| 11. | Currency result | -1,297 | -206 | -1,091 | -529.1 |
| 12. | Investment result for unit-linked life insurance | 539 | 766 | -227 | -29.6 |
| 13. | Insurance finance income or expenses from insurance contracts issued | -4,175 | -5,410 | 1,235 | 22.8 |
| 14. | Insurance finance income or expenses from reinsurance contracts held | 64 | 80 | -16 | -19.8 |
| 15. | Insurance finance income or expenses (13+14) | -4,111 | -5,330 | 1,219 | 22.9 |
| 16. | Net financial result (10+11+12+15) | 1,026 | 954 | 72 | 7.5 |
| 17. | Other operating income | 1,226 | 954 | 272 | 28.6 |
| 18. | Other operating expenses | -2,744 | -2,460 | -283 | -11.5 |
| 19. | Operating result (9+16+17+18) | 7,418 | 6,230 | 1,189 | 19.1 |
| 20. | Net finance costs | -173 | -148 | -25 | -16.6 |
| 21. | Taxes on income | -2,069 | -1,459 | -611 | -41.9 |
| 22. | Net result (19+20+21) | 5,176 | 4,623 | 553 | 12.0 |
| Thereof: | |||||
| Attributable to Munich Reinsurance Company equity holders | 5,173 | 4,624 | 550 | 11.9 | |
| Attributable to non-controlling interests | 2 | -1 | 3 | – | |
| € | € | € | |||
| Earnings per share | 39.73 | 34.67 | 5.05 | 14.6 |
Previous year´s figures adjusted due to an accounting policy change for recognition of acquisition costs in the segment ERGO Germany.
Previous year's figures adjusted due to a reclassification of currency translation differences on insurance-related financial instruments to the currency result.
{11}------------------------------------------------
Consolidated income statement1,2
| Q3 2025 Q3 2024 Mio. € €m €m 1. Insurance revenue from insurance contracts issued 14,575 15,496 -920 Insurance service expenses from insurance contracts issued 2. -11,485 -13,511 2,026 Claims expenses -9,488 -11,526 2,038 Changes from underlying items 241 197 44 Administration and acquisition costs -2,237 -2,182 -55 Other insurance service expenses -1 0 -1 3. Insurance service result from insurance contracts issued (1+2) 3,091 1,985 1,106 Insurance revenue ceded from reinsurance contracts held 4. -425 -559 134 |
Change |
|---|---|
| % | |
| -5.9 | |
| 15.0 | |
| 17.7 | |
| 22.6 | |
| -2.5 | |
| – | |
| 55.7 | |
| 23.9 | |
| 5. Income from reinsurance contracts held 27 96 -69 -71.7 |
|
| 6. Insurance service result from reinsurance contracts held (4+5) -398 -464 65 |
14.1 |
| 7. Insurance service result (3+6) 2,692 1,521 1,172 |
77.0 |
| 8. Result from insurance-related financial instruments 130 176 -46 -26.1 |
|
| Total technical result (7+8) 9. 2,822 1,696 1,126 |
66.4 |
| 10. Investment result 2,385 2,091 294 |
14.1 |
| Currency result 11. -189 -462 272 |
59.0 |
| 12. Investment result for unit-linked life insurance 347 112 235 210.2 |
|
| 13. Insurance finance income or expenses from insurance contracts issued -1,751 -1,826 75 |
4.1 |
| Insurance finance income or expenses from reinsurance contracts held 14. 21 27 -5 -19.4 |
|
| 15. Insurance finance income or expenses (13+14) -1,730 -1,799 70 |
3.9 |
| Net financial result (10+11+12+15) 16. 813 -58 871 |
– |
| 17. Other operating income 578 286 292 102.3 |
|
| Other operating expenses 18. -1,177 -763 -414 -54.2 |
|
| 19. Operating result (9+16+17+18) 3,036 1,161 1,876 161.6 |
|
| Net finance costs 20. -60 -57 -4 |
-6.6 |
| Taxes on income 21. -979 -197 -782 -397.7 |
|
| 22. Net result (19+20+21) 1,997 907 1,090 120.1 |
|
| Thereof: | |
| Attributable to Munich Reinsurance Company equity holders 2,003 907 1,096 120.8 |
|
| Attributable to non-controlling interests -6 0 -6 |
– |
| € € € |
|
| Earnings per share 15.48 6.85 8.63 126.0 |
Previous year´s figures adjusted due to an accounting policy change for recognition of acquisition costs in the segment ERGO Germany.
Previous year's figures adjusted due to a reclassification of currency translation differences on insurance-related financial instruments to the currency result.
{12}------------------------------------------------
Segment balance sheet1,2
Segment assets
| Reinsurance | ERGO | Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Specialty | ||||||||||||
| Life and health | Property-casualty | Insurance | Germany | International | ||||||||
| €m | 30.9.2025 | 31.12.2024 | 30.9.2025 | 31.12.2024 | 30.9.2025 | 31.12.2024 | 30.9.2025 | 31.12.2024 | 30.9.2025 | 31.12.2024 | 30.9.2025 | 31.12.2024 |
| A. Intangible assets | 252 | 286 | 1,062 | 1,205 | 929 | 1,046 | 1,317 | 1,337 | 2,279 | 387 | 5,838 | 4,262 |
| B. Reinsurance contracts held that are assets | 452 | 722 | 1,572 | 1,793 | 661 | 686 | 345 | 428 | 643 | 493 | 3,672 | 4,123 |
| C. Insurance contracts issued that are assets | 6,105 | 6,261 | 73 | 103 | 100 | 204 | 499 | 561 | 77 | 79 | 6,854 | 7,208 |
| D. Investments | 16,532 | 19,077 | 65,584 | 67,485 | 15,919 | 15,208 | 110,949 | 112,424 | 16,591 | 16,523 | 225,575 | 230,716 |
| E. Investments for unit-linked life insurance | 0 | 0 | 0 | 0 | 0 | 0 | 6,735 | 6,430 | 2,949 | 2,756 | 9,684 | 9,186 |
| F. Insurance-related financial instruments | 8,000 | 8,426 | 334 | 785 | 0 | 0 | 351 | 353 | 0 | 0 | 8,684 | 9,563 |
| G. Non-current assets held for sale | 0 | 12 | 13 | 147 | 69 | 2 | 629 | 613 | 27 | 0 | 739 | 774 |
| H. Other segment assets | 3,010 | 3,350 | 6,155 | 7,693 | 1,544 | 2,091 | 5,700 | 6,133 | 1,672 | 1,341 | 18,080 | 20,609 |
| Total segment assets | 34,350 | 38,134 | 74,793 | 79,212 | 19,222 | 19,238 | 126,524 | 128,280 | 24,238 | 21,579 | 279,128 | 286,442 |
| Segment equity and liabilities | |
|---|---|
| -------------------------------- | -- |
| Reinsurance | ERGO | Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Specialty | ||||||||||||
| Life and health | Property-casualty | Insurance | Germany | International | ||||||||
| €m | 30.9.2025 | 31.12.2024 | 30.9.2025 | 31.12.2024 | 30.9.2025 | 31.12.2024 | 30.9.2025 | 31.12.2024 | 30.9.2025 | 31.12.2024 | 30.9.2025 | 31.12.2024 |
| A. Subordinated liabilities | 895 | 837 | 6,250 | 5,272 | 246 | 198 | 0 | 0 | 13 | 13 | 7,404 | 6,321 |
| B. Reinsurance contracts held that are liabilities | 3 | 188 | 13 | 57 | 42 | 36 | 107 | 112 | 123 | 130 | 287 | 523 |
| C. Insurance contracts issued that are liabilities | 15,403 | 16,499 | 52,543 | 55,935 | 11,279 | 11,956 | 120,625 | 121,930 | 16,263 | 15,949 | 216,113 | 222,269 |
| I. Liability for remaining coverage | 10,127 | 8,483 | -2,813 | -4,228 | 2,349 | 2,256 | 111,927 | 113,401 | 12,612 | 12,648 | 134,202 | 132,560 |
| III. Liability for incurred claims | 5,277 | 8,016 | 55,356 | 60,163 | 8,929 | 9,701 | 8,698 | 8,529 | 3,651 | 3,294 | 81,911 | 89,702 |
| II. Other technical Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 7 |
| D. Other provisions | 129 | 147 | 368 | 457 | 183 | 194 | 1,619 | 1,589 | 534 | 373 | 2,833 | 2,760 |
| Liabilities related to non-current assets held for sale E. |
0 | 2 | 34 | 21 | 4 | 0 | 0 | 0 | 16 | 0 | 54 | 23 |
| F. Other segment liabilities | 6,562 | 6,282 | 5,567 | 6,690 | 1,854 | 2,044 | 3,666 | 4,273 | 2,375 | 2,356 | 20,024 | 21,644 |
| Total segment liabilities | 22,993 | 23,955 | 64,774 | 68,431 | 13,607 | 14,429 | 126,017 | 127,904 | 19,324 | 18,822 | 246,714 | 253,541 |
| Equity | 32,414 | 32,901 | ||||||||||
| Total equity and liabilities | 279,128 | 286,442 | ||||||||||
| Selected balance sheet items: | ||||||||||||
| Risk adjustment for non-financial risk (total)3 | 3,384 | 3,605 | 334 | 361 | 43 | 47 | 702 | 731 | 181 | 146 | 4,643 | 4,891 |
| Contractual service margin (total)3 | 14,946 | 14,455 | 356 | 272 | 0 | 0 | 9,821 | 9,944 | 2,610 | 2,884 | 27,733 | 27,556 |
| Loss component by segment (total) | 226 | 243 | 436 | 480 | 73 | 108 | 87 | 136 | 259 | 266 | 1,080 | 1,232 |
Previous year's figures adjusted due to change in segment reporting.
Previous year´s figures adjusted due to an accounting policy change for recognition of acquisition costs in the segment ERGO Germany.
Risk adjustment for non-financial risk and contractual service margin include ceded parts.
{13}------------------------------------------------
Total Reinsurance ERGO
| Global Specialty | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Life and health | Property-casualty | Insurance | Germany | International | ||||||||
| €m | Q1–3 2025 | Q1–3 2024 | Q1–3 2025 | Q1–3 2024 | Q1–3 2025 | Q1–3 2024 | Q1–3 2025 | Q1–3 2024 | Q1–3 2025 | Q1–3 2024 | Q1–3 2025 | Q1–3 2024 |
| 1. Insurance revenue from insurance contracts issued | 9,033 | 8,924 | 13,646 | 14,585 | 6,464 | 6,448 | 11,192 | 11,049 | 4,827 | 4,504 | 45,162 | 45,510 |
| 2. Insurance service expenses from insurance contracts issued | -8,117 | -7,727 | -9,261 | -10,917 | -5,388 | -5,815 | -9,862 | -9,898 | -4,205 | -3,981 | -36,833 | -38,337 |
| Claims expenses | -7,794 | -7,430 | -7,996 | -9,667 | -3,389 | -3,945 | -8,537 | -8,292 | -2,908 | -2,805 | -30,624 | -32,139 |
| Changes from underlying items | 0 | 0 | 0 | 0 | 0 | 0 | 617 | 410 | -19 | -10 | 598 | 400 |
| Admin and acquisition cost | -321 | -297 | -1,265 | -1,250 | -1,999 | -1,869 | -1,942 | -2,016 | -1,278 | -1,166 | -6,806 | -6,598 |
| Other insurance service expenses | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| 3. Insurance service result from insurance contracts issued (1+2) | 916 | 1,196 | 4,385 | 3,667 | 1,076 | 634 | 1,330 | 1,151 | 621 | 524 | 8,329 | 7,172 |
| 4. Insurance revenue ceded from reinsurance contracts held | -94 | -198 | -515 | -600 | -310 | -259 | -83 | -92 | -169 | -205 | -1,171 | -1,355 |
| 5. Income from reinsurance contracts held | 73 | 173 | 99 | 28 | 108 | 164 | 8 | 69 | 100 | 118 | 388 | 552 |
| 6. Insurance service result from reinsurance contracts held (4+5) | -21 | -26 | -416 | -572 | -202 | -95 | -75 | -23 | -69 | -87 | -783 | -803 |
| 7. Insurance service result (3+6) | 895 | 1,170 | 3,969 | 3,095 | 875 | 539 | 1,255 | 1,128 | 553 | 437 | 7,546 | 6,369 |
| 8. Result from insurance-related financial instruments | 332 | 389 | 43 | 47 | 0 | 0 | -10 | -21 | -1 | -1 | 364 | 413 |
| 9. Total technical result (7+8) | 1,226 | 1,559 | 4,012 | 3,142 | 875 | 538 | 1,246 | 1,107 | 552 | 436 | 7,910 | 6,782 |
| 10. Investment result | 475 | 499 | 2,246 | 1,799 | 393 | 319 | 2,176 | 2,727 | 604 | 380 | 5,894 | 5,724 |
| 11. Currency result | -17 | 19 | -672 | -26 | -41 | -34 | -560 | -145 | -7 | -19 | -1,297 | -206 |
| 12. Investment result for unit-linked life insurance | 0 | 0 | 0 | 0 | 0 | 0 | 388 | 537 | 152 | 229 | 539 | 766 |
| 13. Insurance finance income or expenses from insurance contracts issued | -114 | -120 | -1,294 | -1,342 | -343 | -344 | -1,999 | -3,096 | -425 | -509 | -4,175 | -5,410 |
| 14. Insurance finance income or expenses from reinsurance contracts held | 1 | 1 | 36 | 51 | 16 | 17 | 3 | 2 | 8 | 9 | 64 | 80 |
| 15. Insurance finance income or expenses (13+14) | -113 | -119 | -1,258 | -1,291 | -328 | -327 | -1,996 | -3,093 | -417 | -500 | -4,111 | -5,330 |
| 16. Net financial result (10+11+12+15) | 345 | 399 | 317 | 482 | 24 | -42 | 7 | 25 | 332 | 90 | 1,026 | 954 |
| 17. Other operating income | 244 | 242 | 221 | 186 | 246 | 222 | 247 | 181 | 269 | 123 | 1,226 | 954 |
| 18. Other operating expenses | -325 | -337 | -541 | -586 | -463 | -410 | -890 | -782 | -523 | -345 | -2,744 | -2,460 |
| 19. Operating result (9+16+17+18) | 1,490 | 1,864 | 4,008 | 3,224 | 681 | 308 | 609 | 531 | 630 | 304 | 7,418 | 6,230 |
| 20. Net finance costs | -19 | 9 | -117 | -119 | -17 | -15 | 17 | 12 | -38 | -36 | -173 | -148 |
| 21. Taxes on income | -340 | -392 | -1,167 | -831 | -139 | -53 | -351 | -149 | -71 | -34 | -2,069 | -1,459 |
| 22. Net result (19+20+21) | 1,131 | 1,481 | 2,724 | 2,273 | 525 | 239 | 275 | 395 | 521 | 234 | 5,176 | 4,623 |
Previous year's figures adjusted due to change in segment reporting.
Previous year's figures adjusted due to a reclassification of currency translation differences on insurance-related financial instruments to the currency result.
Previous year´s figures adjusted due to an accounting policy change for recognition of acquisition costs in the segment ERGO Germany.
{14}------------------------------------------------
Segment income statement1,2,3
| Global Specialty | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Life and health | Property-casualty | Insurance | Germany | International | ||||||||
| €m | Q3 2025 | Q3 2024 | Q3 2025 | Q3 2024 | Q3 2025 | Q3 2024 | Q3 2025 | Q3 2024 | Q3 2025 | Q3 2024 | Q3 2025 | Q3 2024 |
| 1. Insurance revenue from insurance contracts issued | 2,868 | 2,936 | 4,241 | 5,055 | 2,153 | 2,233 | 3,749 | 3,784 | 1,564 | 1,487 | 14,575 | 15,496 |
| 2. Insurance service expenses from insurance contracts issued | -2,658 | -2,557 | -2,451 | -4,157 | -1,747 | -2,038 | -3,269 | -3,398 | -1,360 | -1,361 | -11,485 | -13,511 |
| Claims expenses | -2,561 | -2,471 | -2,051 | -3,745 | -1,078 | -1,388 | -2,872 | -2,942 | -927 | -980 | -9,488 | -11,526 |
| Changes from underlying items | 0 | 0 | 0 | 0 | 0 | 0 | 249 | 213 | -8 | -16 | 241 | 197 |
| Admin and acquisition cost | -97 | -87 | -400 | -412 | -669 | -650 | -646 | -668 | -425 | -365 | -2,237 | -2,182 |
| Other insurance service expenses | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| 3. Insurance service result from insurance contracts issued (1+2) | 210 | 379 | 1,790 | 897 | 406 | 196 | 480 | 386 | 205 | 126 | 3,091 | 1,985 |
| 4. Insurance revenue ceded from reinsurance contracts held | -23 | -134 | -192 | -247 | -121 | -74 | -29 | -30 | -61 | -74 | -425 | -559 |
| 5. Income from reinsurance contracts held | 8 | 121 | -88 | -146 | 64 | 38 | 10 | 37 | 33 | 45 | 27 | 96 |
| 6. Insurance service result from reinsurance contracts held (4+5) | -15 | -13 | -280 | -393 | -57 | -36 | -19 | 7 | -28 | -29 | -398 | -464 |
| 7. Insurance service result (3+6) | 195 | 366 | 1,510 | 504 | 349 | 160 | 461 | 393 | 177 | 97 | 2,692 | 1,521 |
| 8. Result from insurance-related financial instruments | 119 | 141 | 17 | 27 | 0 | 0 | -6 | 9 | 0 | -1 | 130 | 176 |
| 9. Total technical result (7+8) | 314 | 507 | 1,527 | 531 | 349 | 160 | 456 | 402 | 177 | 97 | 2,822 | 1,696 |
| 10. Investment result | 158 | 175 | 857 | 531 | 113 | 98 | 867 | 1,158 | 389 | 129 | 2,385 | 2,091 |
| 11. Currency result | -9 | -10 | -103 | -220 | 10 | -43 | -90 | -188 | 2 | -2 | -189 | -462 |
| 12. Investment result for unit-linked life insurance | 0 | 0 | 0 | 0 | 0 | 0 | 273 | 75 | 74 | 37 | 347 | 112 |
| 13. Insurance finance income or expenses from insurance contracts issued | -32 | -34 | -395 | -439 | -108 | -120 | -1,044 | -1,086 | -172 | -147 | -1,751 | -1,826 |
| 14. Insurance finance income or expenses from reinsurance contracts held | 0 | 0 | 11 | 16 | 5 | 6 | 2 | 1 | 3 | 3 | 21 | 27 |
| 15. Insurance finance income or expenses (13+14) | -32 | -33 | -384 | -423 | -103 | -113 | -1,042 | -1,085 | -169 | -144 | -1,730 | -1,799 |
| 16. Net financial result (10+11+12+15) | 117 | 132 | 371 | -112 | 20 | -58 | 9 | -40 | 296 | 20 | 813 | -58 |
| 17. Other operating income | 78 | 81 | 100 | 51 | 78 | 81 | 142 | 46 | 180 | 27 | 578 | 286 |
| 18. Other operating expenses | -122 | -116 | -207 | -152 | -148 | -148 | -416 | -246 | -284 | -100 | -1,177 | -763 |
| 19. Operating result (9+16+17+18) | 387 | 604 | 1,790 | 318 | 300 | 34 | 190 | 161 | 369 | 44 | 3,036 | 1,161 |
| 20. Net finance costs | -8 | 2 | -41 | -46 | -7 | -5 | 8 | 4 | -13 | -12 | -60 | -57 |
| 21. Taxes on income | -93 | -125 | -562 | -9 | -72 | -7 | -218 | -47 | -32 | -9 | -979 | -197 |
| 22. Net result (19+20+21) | 286 | 481 | 1,187 | 263 | 221 | 22 | -21 | 118 | 324 | 23 | 1,997 | 907 |
Reinsurance
Total
ERGO
Previous year's figures adjusted due to change in segment reporting.
Previous year's figures adjusted due to a reclassification of currency translation differences on insurance-related financial instruments to the currency result.
Previous year´s figures adjusted due to an accounting policy change for recognition of acquisition costs in the segment ERGO Germany.
{15}------------------------------------------------
Notes on determining the combined ratio1
| Reinsurance | ERGO | |||||||
|---|---|---|---|---|---|---|---|---|
| Global Specialty | Property-casualty | |||||||
| €m | Q1–3 2025 | Property-casualty Q1–3 2024 |
Insurance Q1–3 2025 |
Q1–3 2024 | Germany2 Q1–3 2025 |
Q1–3 2024 | International3 Q1–3 2025 |
Q1–3 2024 |
| Insurance revenue from insurance contracts issued | 13,646 | 14,585 | 6,464 | 6,448 | 3,484 | 3,529 | 3,873 | 3,620 |
| Insurance revenue ceded from reinsurance contracts held | -515 | -600 | -310 | -259 | -74 | -81 | -159 | -196 |
| Insurance revenue (net) | 13,131 | 13,984 | 6,154 | 6,189 | 3,410 | 3,448 | 3,714 | 3,424 |
| Insurance service expenses from insurance contracts issued | -9,261 | -10,917 | -5,388 | -5,815 | -3,032 | -3,137 | -3,405 | -3,277 |
| Income from reinsurance contracts held | 99 | 28 | 108 | 164 | 2 | 61 | 97 | 113 |
| Insurance service expenses (net) | -9,162 | -10,889 | -5,280 | -5,650 | -3,030 | -3,077 | -3,308 | -3,164 |
| Combined ratio | % 69.8 |
77.9 | 85.8 | 91.3 | 88.8 | 89.2 | 89.1 | 92.4 |
Previous year's figures adjusted due to change in segment reporting.
Previous year´s figures adjusted due to an accounting policy change for recognition of acquisition costs in the segment ERGO Germany.
Property-casualty business, travel insurance business and short-term health insurance business (excluding health insurance conducted like life insurance).
{16}------------------------------------------------
Total technical result1
| Reinsurance | ERGO | ||||||
|---|---|---|---|---|---|---|---|
| Life and Health2 | Germany3,4 | International4 | |||||
| €m | Q1–3 2025 | Q1–3 2024 | Q1–3 2025 | Q1–3 2024 | Q1–3 2025 | Q1–3 2024 | |
| Release of CSM | 848 | 770 | 619 | 601 | 181 | 154 | |
| Release of risk adjustment (non-PAA) | 226 | 227 | 31 | 25 | 7 | 8 | |
| Experience adjustments not adjusted against CSM (non-PAA) | -149 | 233 | 59 | 30 | 48 | 61 | |
| Onerous contracts and changes not affecting CSM (non-PAA) | -31 | -60 | -6 | -17 | -22 | -13 | |
| Insurance service result from PAA business | 0 | 0 | 171 | 118 | 21 | 6 | |
| Insurance service result | 895 | 1,170 | 875 | 757 | 235 | 217 | |
| Result from insurance-related financial instruments | 332 | 389 | -10 | -21 | 0 | 0 | |
| Total technical result | 1,226 | 1,559 | 865 | 736 | 235 | 217 |
Previous year's figures adjusted due to change in segment reporting.
Previous year's figures adjusted due to a reclassification of currency translation differences on insurance-related financial instruments to the currency result.
Previous year´s figures adjusted due to an accounting policy change for recognition of acquisition costs in the segment ERGO Germany.
Life & Health business
{17}------------------------------------------------
Total technical result1
| Reinsurance | ERGO | |||||
|---|---|---|---|---|---|---|
| Life and Health2 | Germany3,4 | International4 | ||||
| €m | Q3 2025 | Q3 2024 | Q3 2025 | Q3 2024 | Q3 2025 | Q3 2024 |
| Release of CSM | 289 | 247 | 197 | 195 | 57 | 36 |
| Release of risk adjustment (non-PAA) | 74 | 75 | 10 | 8 | 2 | 3 |
| Experience adjustments not adjusted against CSM (non-PAA) | -158 | 41 | 61 | 21 | 23 | 33 |
| Onerous contracts and changes not affecting CSM (non-PAA) | -10 | 2 | -1 | -5 | -17 | -18 |
| Insurance service result from PAA business | 0 | 0 | 63 | 40 | 11 | 10 |
| Insurance service result | 195 | 366 | 330 | 260 | 75 | 63 |
| Result from insurance-related financial instruments | 119 | 141 | -6 | 9 | 0 | 0 |
| Total technical result | 314 | 507 | 324 | 269 | 75 | 63 |
Previous year's figures adjusted due to change in segment reporting.
Previous year's figures adjusted due to a reclassification of currency translation differences on insurance-related financial instruments to the currency result.
Previous year´s figures adjusted due to an accounting policy change for recognition of acquisition costs in the segment ERGO Germany.
4 Life & Health business
{18}------------------------------------------------
CSM/RA Development1
| Reinsurance | ERGO | ||||||
|---|---|---|---|---|---|---|---|
| €m | Life and health | Germany2 | International2 | ||||
| CSM | RA | CSM | RA | CSM | RA | ||
| 31.12.2024 | 14,455 | 3,605 | 9,562 | 647 | 2,654 | 111 | |
| New contracts added | 1,815 | 337 | 154 | 6 | 236 | 9 | |
| Accretion of interest | 288 | 71 | 0 | 0 | 27 | 1 | |
| Operating changes | 335 | -93 | 347 | -16 | -349 | 35 | |
| Change in financial effects | -1,356 | -277 | 0 | 0 | 0 | -7 | |
| Other | 258 | -34 | 0 | 0 | 0 | 0 | |
| Release (through P&L) | -848 | -226 | -619 | -31 | -181 | -7 | |
| 30.9.2025 | 14,946 | 3,384 | 9,445 | 606 | 2,388 | 142 |
Net of reinsurance.
Life & Health business
{19}------------------------------------------------
Notes on determining the annualised return on equity (RoE)1
| Reinsurance | ERGO | Total | ||||||
|---|---|---|---|---|---|---|---|---|
| €m | 30.9.2025 | 31.12.2024 | 30.9.2025 | 31.12.2024 | 30.9.2025 | 31.12.2024 | ||
| Assets | 128,366 | 136,583 | 150,762 | 149,859 | 279,128 | 286,442 | ||
| Liabilites | 101,373 | 106,815 | 145,340 | 146,726 | 246,714 | 253,541 | ||
| Adjustments used in the calculation of equity | ||||||||
| Other reserves - Fair value measurement, measurement of insurance contracts, currency translation, hedge relationships |
-762 | 1,087 | -609 | -690 | -1,371 | 397 | ||
| Adjustment item for material asset transfers | ||||||||
| between reinsurance and ERGO | 1,133 | 1,094 | -1,133 | -1,094 | 0 | 0 | ||
| Adjusted equity | 26,621 | 27,587 | 7,163 | 4,917 | 33,785 | 32,504 | ||
| Q1–3 2025 | Q1–3 2025 | Q1–3 2025 | ||||||
| Average adjusted equity | 27,104 | 6,040 | 33,144 | |||||
| Net result | 4,380 | 796 | 5,176 | |||||
| Return on equity (RoE) | % | 21.5 | 17.6 | 20.8 |
Previous year´s figures adjusted due to an accounting policy change for recognition of acquisition costs in the segment ERGO Germany.
Notes on determining the annualised return on equity (RoE)1
| Reinsurance | ERGO | Total | ||||||
|---|---|---|---|---|---|---|---|---|
| €m | 30.9.2024 | 31.12.2023 | 30.9.2024 | 31.12.2023 | 30.9.2024 | 31.12.2023 | ||
| Assets | 129,875 | 125,994 | 150,101 | 147,735 | 279,976 | 273,729 | ||
| Liabilites | 101,564 | 99,634 | 146,921 | 144,186 | 248,485 | 243,821 | ||
| Adjustments used in the calculation of equity | ||||||||
| Other reserves - Fair value measurement, measurement of insurance contracts, currency translation, hedge relationships |
465 | 189 | -641 | -475 | -176 | -286 | ||
| Adjustment item for material asset transfers | ||||||||
| between reinsurance and ERGO | 976 | 940 | -976 | -940 | 0 | 0 | ||
| Adjusted equity | 26,870 | 25,231 | 4,797 | 4,963 | 31,667 | 30,195 | ||
| Q1–3 2024 | Q1–3 2024 | Q1–3 2024 | ||||||
| Average adjusted equity | 26,051 | 4,880 | 30,931 | |||||
| Net result | 3,993 | 629 | 4,623 | |||||
| Return on equity (RoE) | % | 20.4 | 17.2 | 19.9 |
Figures as at 31 December 2023 and 30 September 2024 adjusted due to an accounting policy change for recognition of acquisition costs in the segment ERGO Germany.